Home/Filings/4/0001104659-23-129186
4//SEC Filing

McBarron Paul 4

Accession 0001104659-23-129186

CIK 0001130166other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 4:05 PM ET

Size

7.5 KB

Accession

0001104659-23-129186

Insider Transaction Report

Form 4
Period: 2023-12-21
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
  • Purchase

    Warrants (right to buy)

    2023-12-21+1,8861,886 total
    Exercise: $3.19From: 2023-12-21Exp: 2030-12-21Common Stock (1,886 underlying)
  • Purchase

    Common Stock

    2023-12-21$3.31/sh+1,886$6,25233,378 total
Footnotes (2)
  • [F1]The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer.
  • [F2]Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant.

Issuer

Cyclacel Pharmaceuticals, Inc.

CIK 0001130166

Entity typeother

Related Parties

1
  • filerCIK 0001357397

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 4:05 PM ET
Size
7.5 KB